INTRAVENOUS INJECTION FORMULA DESIGNED TO INCREASE IMMUNITY Russian patent published in 2021 - IPC C12N1/20 A61K35/744 A61P37/04 

FIELD: medicine.

SUBSTANCE: invention relates to an injectable composition for enhancing specific immunity. The proposed composition for injection is a composition for intravenous injection, where the main component is inactivated lactic acid bacteria Enterococcus faecium (CICC6049), purchased from the China Center of Industrial Culture Collection (CICC). At the same time, using Gram staining and immersion microscopy of the inactivated lactic acid bacteria helped to reveal that the inactivated lactic acid bacteria retain the morphology of the intact bacteria. In this case, the number of intact cells of the inactivated lactic acid bacteria in one milliliter of the composition for injection is 10⁵–10¹².

EFFECT: invention provides increased specific immunity.

5 cl, 10 tbl, 11 ex, 3 dwg